OpenURL Connection Search

Select item for more details and to access through your institution.

NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2841, doi. 10.1007/s00432-022-04064-4
By:
- Kajiwara, Takeshi;
- Nishina, Tomohiro;
- Nakasya, Akio;
- Yamashita, Natsumi;
- Yamashita, Riu;
- Nakamura, Yoshiaki;
- Shiozawa, Manabu;
- Yuki, Satoshi;
- Taniguchi, Hiroya;
- Hara, Hiroki;
- Ohta, Takashi;
- Esaki, Taito;
- Shinozaki, Eiji;
- Takashima, Atsuo;
- Moriwaki, Toshikazu;
- Denda, Tadamichi;
- Ohtsubo, Koushiro;
- Sunakawa, Yu;
- Horita, Yosuke;
- Kawakami, Hisato
Publication type:
Article
Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.
Published in:
Internal Medicine, 2022, v. 61, n. 15, p. 2255, doi. 10.2169/internalmedicine.8736-21
By:
- Kaori Hino;
- Tomohiro Nishina;
- Yuuki Numata;
- Akinori Asagi;
- Tomonori Inoue;
- Megumi Yoshimatsu;
- Chihiro Sakaguchi;
- Akio Nakasya;
- Norifumi Nishide;
- Takeshi Kajiwara;
- Takashi Terao;
- Seijin Nadano;
- Kaori Marui;
- Yusuke Okujima;
- Masahito Kokubu;
- Yoshiki Imamura;
- Kozue Kanemitsu;
- Mitsuhito Koizumi;
- Teru Kumagi;
- Yoichi Hiasa
Publication type:
Article
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
Published in:
Investigational New Drugs, 2022, v. 40, n. 3, p. 614, doi. 10.1007/s10637-022-01223-9
By:
- Mizukami, Takuro;
- Minashi, Keiko;
- Hara, Hiroki;
- Nishina, Tomohiro;
- Amanuma, Yusuke;
- Takahashi, Naoki;
- Nakasya, Akio;
- Takahashi, Masaki;
- Nakajima, Takako Eguchi
Publication type:
Article
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 684, doi. 10.1007/s10147-022-02114-y
By:
- Nakasya, Akio;
- Hagiwara, Yuya;
- Ikoma, Tatsuki;
- Kurioka, Yusuke;
- Matsumoto, Toshihiko;
- Yamamoto, Yoshiyuki;
- Tsuduki, Takao;
- Kajiwara, Takeshi;
- Moriwaki, Toshikazu;
- Nishina, Tomohiro;
- Yamashita, Natsumi;
- Hyodo, Ichinosuke
Publication type:
Article
Characteristic distribution of maculopapular rash caused by gemcitabine‐based chemotherapy.
Published in:
Journal of Dermatology, 2021, v. 48, n. 2, p. 215, doi. 10.1111/1346-8138.15654
By:
- Tohyama, Mikiko;
- Asagi, Akinori;
- Nakasya, Akio;
- Iuchi, Shunsuke;
- Hashine, Katsuyoshi
Publication type:
Article

Found: 5

NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).

Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.

An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.

Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).

Characteristic distribution of maculopapular rash caused by gemcitabine‐based chemotherapy.